Search Results 1601-1610 of 19200 for Neutrophil

  1. Hematology - Clinical trials

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

  2. Evaluating the Effectiveness of Intravenous Immunoglobulin Therapy in Autoimmune Autonomic Ganglionopathy - Mayo Clinic

    Platelet count <100,000/mL, Hemoglobin <8.5 g/dL, Neutrophils <1.5 x 103/mL. Serum IgA deficiency: Immunoglobulin A (IgA) level < 7 mg/dL. History of ...

  3. ... NEUTROPHILIC CYTOPLASMIC AB,124 302000026,HC ANTINUCLEAR ANTIBODIES/ANA,127 302000028,HC ANTISTREPTOLYSIN O TITER,78 302000030,HC ANTI-TETANUS TOXOID IGG ...

  4. Targeted Drug Therapy Clinical Trials - Mayo Clinic Research

    ... neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) ...

  5. Publications - Andre M. Oliveira, M.D., Ph.D. - Mayo Clinic

    Oncolytic measles virotherapy encoding the neutrophil-activating protein is effective in synovial sarcoma. Molecular Therapy Oncology. 2025; 33 (4):201062

  6. A Study to Evaluate TAB006, as Monotherapy and in Combination with Toripalimab, in Patients with Previously Treated, Advanced Malignancies - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1.5×10^9/L (1,500/mm^3) with no administration of hematopoietic growth factors for at least 14 days prior to the planned ...

  7. Publications - Melissa R. Snyder, Ph.D. - Mayo Clinic

    ... neutrophil cytoplasmic antibody associated vasculitis. Rheumatology (Oxford). 2018 Apr 1; 57 (4):639-650. View PubMed; Wongjarupong N, Negron-Ocasio GM ...

  8. Cell Therapy Clinical Trials

    ... neutrophil cytoplasmic antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. A Study to Analyze AVB-114 to ...

  9. Breast Clinic - Clinical trials

    MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

  10. Clinical trials - Oncology (Medical)

    MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...